<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35527262</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Print">2047-9158</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>09</Day>
            </PubDate>
          </JournalIssue>
          <Title>Translational neurodegeneration</Title>
          <ISOAbbreviation>Transl Neurodegener</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A new paradigm for diagnosis of neurodegenerative diseases: peripheral exosomes of brain origin.</ArticleTitle>
        <Pagination>
          <StartPage>28</StartPage>
          <MedlinePgn>28</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">28</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s40035-022-00301-5</ELocationID>
        <Abstract>
          <AbstractText>Neurodegenerative diseases are a heterogeneous group of maladies, characterized by progressive loss of neurons. These diseases involve an intricate pattern of cross-talk between different types of cells to maintain specific signaling pathways. A component of such intercellular cross-talk is the exchange of various types of extracellular vesicles (EVs). Exosomes are a subset of EVs, which are increasingly being known for the role they play in the pathogenesis and progression of neurodegenerative diseases, e.g., synucleinopathies and tauopathies. The ability of the central nervous system exosomes to cross the blood-brain barrier into blood has generated enthusiasm in their study as potential biomarkers. However, the lack of standardized, efficient, and ultra-sensitive methods for the isolation and detection of brain-derived exosomes has hampered the development of effective biomarkers. Exosomes mirror heterogeneous biological changes that occur during the progression of these incurable illnesses, potentially offering a more comprehensive outlook of neurodegenerative disease diagnosis, progression and treatment. In this review, we aim to discuss the challenges and opportunities of peripheral biofluid-based brain-exosomes in the diagnosis and biomarker discovery of Alzheimer's and Parkinson's diseases. In the later part, we discuss the traditional and emerging methods used for the isolation of exosomes and compare their advantages and disadvantages in clinical settings.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Younas</LastName>
            <ForeName>Neelam</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0003-0421-5247</Identifier>
            <AffiliationInfo>
              <Affiliation>Prion Research Group, Department of Neurology, National Reference Center for Surveillance of TSE, Universitätsklinikum Göttingen: Universitätsmedizin Göttingen, Georg-August University, Göttingen, Germany, Robert-Koch-Strasse 40, 37075, Göttingen, Germany. neelam.younas@med.uni-goettingen.de.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fernandez Flores</LastName>
            <ForeName>Leticia Camila</ForeName>
            <Initials>LC</Initials>
            <AffiliationInfo>
              <Affiliation>Prion Research Group, Department of Neurology, National Reference Center for Surveillance of TSE, Universitätsklinikum Göttingen: Universitätsmedizin Göttingen, Georg-August University, Göttingen, Germany, Robert-Koch-Strasse 40, 37075, Göttingen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hopfner</LastName>
            <ForeName>Franziska</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Hannover Medical School, Medizinische Hochschule Hannover, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Höglinger</LastName>
            <ForeName>Günter U</ForeName>
            <Initials>GU</Initials>
            <AffiliationInfo>
              <Affiliation>Hannover Medical School, Medizinische Hochschule Hannover, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zerr</LastName>
            <ForeName>Inga</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Prion Research Group, Department of Neurology, National Reference Center for Surveillance of TSE, Universitätsklinikum Göttingen: Universitätsmedizin Göttingen, Georg-August University, Göttingen, Germany, Robert-Koch-Strasse 40, 37075, Göttingen, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Transl Neurodegener</MedlineTA>
        <NlmUniqueID>101591861</NlmUniqueID>
        <ISSNLinking>2047-9158</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055354" MajorTopicYN="Y">Exosomes</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000067128" MajorTopicYN="Y">Extracellular Vesicles</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Alzheimer’s disease</Keyword>
        <Keyword MajorTopicYN="Y">Blood–brain barrier</Keyword>
        <Keyword MajorTopicYN="Y">Central nervous system</Keyword>
        <Keyword MajorTopicYN="Y">Diagnosis</Keyword>
        <Keyword MajorTopicYN="Y">Exosomes</Keyword>
        <Keyword MajorTopicYN="Y">Parkinson’s disease</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>8</Day>
          <Hour>23</Hour>
          <Minute>14</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35527262</ArticleId>
        <ArticleId IdType="pmc">PMC9082915</ArticleId>
        <ArticleId IdType="doi">10.1186/s40035-022-00301-5</ArticleId>
        <ArticleId IdType="pii">10.1186/s40035-022-00301-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Sweeney P, Park H, Baumann M, Dunlop J, Frydman J, Kopito R, et al.  Protein misfolding in neurodegenerative diseases: Implications and strategies. Transl Neurodegener. 2017;6:6. doi: 10.1186/s40035-017-0077-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40035-017-0077-5</ArticleId>
            <ArticleId IdType="pmc">PMC5348787</ArticleId>
            <ArticleId IdType="pubmed">28293421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin Y, Vadukul DM, Gialama D, Ge Y, Thrush R, White JT, et al.  The diagnostic potential of amyloidogenic proteins. Int J Mol Sci. 2021;22(8):4128. doi: 10.3390/ijms22084128.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms22084128</ArticleId>
            <ArticleId IdType="pmc">PMC8074075</ArticleId>
            <ArticleId IdType="pubmed">33923609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Candelise N, Baiardi S, Franceschini A, Rossi M, Parchi P. Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids. Acta Neuropathol Commun. 2020;8(1):117. doi: 10.1186/s40478-020-00990-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40478-020-00990-x</ArticleId>
            <ArticleId IdType="pmc">PMC7382043</ArticleId>
            <ArticleId IdType="pubmed">32711575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robey TT, Panegyres PK. Cerebrospinal fluid biomarkers in neurodegenerative disorders. Future Neurol. 2019;14:1. doi: 10.2217/fnl-2018-0029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2217/fnl-2018-0029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simrén J, Ashton NJ, Blennow K, Zetterberg H. An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead. Curr Opin Neurobiol. 2020;61:29–39. doi: 10.1016/j.conb.2019.11.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.conb.2019.11.019</ArticleId>
            <ArticleId IdType="pubmed">31838254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Llorens F, Kruse N, Karch A, Schmitz M, Zafar S, Gotzmann N, et al.  Validation of α-synuclein as a CSF biomarker for sporadic Creutzfeldt–Jakob disease. Mol Neurobiol. 2018;55(3):2249–2257. doi: 10.1007/s12035-017-0479-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12035-017-0479-5</ArticleId>
            <ArticleId IdType="pmc">PMC5840235</ArticleId>
            <ArticleId IdType="pubmed">28321768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zafar S, Younas N, Zerr I. Subtype specific CSF biomarkers in sporadic Creutzfeldt–Jakob disease. J Alzheimers Dis Parkinsonism. 2017;7:332. doi: 10.4172/2161-0460.1000332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4172/2161-0460.1000332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bang C, Thum T. Exosomes: new players in cell-cell communication. Int J Biochem Cell Biol. 2012;44:2060–2064. doi: 10.1016/j.biocel.2012.08.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2012.08.007</ArticleId>
            <ArticleId IdType="pubmed">22903023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hermann P, Appleby B, Brandel JP, Caughey B, Collins S, Geschwind MD, et al.  Biomarkers and diagnostic guidelines for sporadic Creutzfeldt–Jakob disease. Lancet Neurol. 2021;20:235–246. doi: 10.1016/S1474-4422(20)30477-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(20)30477-4</ArticleId>
            <ArticleId IdType="pmc">PMC8285036</ArticleId>
            <ArticleId IdType="pubmed">33609480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin J, Li J, Huang B, Liu J, Chen X, Chen XM, et al.  Exosomes: novel biomarkers for clinical diagnosis. Sci World J. 2015;2015:657086.</Citation>
        </Reference>
        <Reference>
          <Citation>Lai CPK, Breakefield XO. Role of exosomes/microvesicles in the nervous system and use in emerging therapies. Front Physiol. 2012;3:228. doi: 10.3389/fphys.2012.00228.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphys.2012.00228</ArticleId>
            <ArticleId IdType="pmc">PMC3384085</ArticleId>
            <ArticleId IdType="pubmed">22754538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hornung S, Dutta S, Bitan G. CNS-derived blood exosomes as a promising source of biomarkers: opportunities and challenges. Front Mol Neurosci. 2020;13:38. doi: 10.3389/fnmol.2020.00038.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnmol.2020.00038</ArticleId>
            <ArticleId IdType="pmc">PMC7096580</ArticleId>
            <ArticleId IdType="pubmed">32265650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu X, Zheng T, Zhang B. Exosomes in Parkinson’s disease. Neurosci Bull. 2017;33:331–338. doi: 10.1007/s12264-016-0092-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12264-016-0092-z</ArticleId>
            <ArticleId IdType="pmc">PMC5567508</ArticleId>
            <ArticleId IdType="pubmed">28025780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song Z, Xu Y, Deng W, Zhang L, Zhu H, Yu P, et al.  Brain derived exosomes are a double-edged sword in Alzheimer’s disease. Front Mol Neurosci. 2020;13:79. doi: 10.3389/fnmol.2020.00079.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnmol.2020.00079</ArticleId>
            <ArticleId IdType="pmc">PMC7274346</ArticleId>
            <ArticleId IdType="pubmed">32547364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang XC, Gao JQ. Exosomes as novel bio-carriers for gene and drug delivery. Int J Pharm. 2017;521:167–175. doi: 10.1016/j.ijpharm.2017.02.038.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijpharm.2017.02.038</ArticleId>
            <ArticleId IdType="pubmed">28216464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mathieu M, Martin-Jaular L, Lavieu G, Théry C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21:9–17. doi: 10.1038/s41556-018-0250-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41556-018-0250-9</ArticleId>
            <ArticleId IdType="pubmed">30602770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yáñez-Mó M, Siljander PRM, Andreu Z, Zavec AB, Borràs FE, Buzas EI, et al.  Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066. doi: 10.3402/jev.v4.27066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3402/jev.v4.27066</ArticleId>
            <ArticleId IdType="pmc">PMC4433489</ArticleId>
            <ArticleId IdType="pubmed">25979354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santavanond JP, Rutter SF, Atkin-Smith GK, Poon IKH. Apoptotic bodies: mechanism of formation, isolation and functional relevance. Subcell Biochem. 2021;97:61–88. doi: 10.1007/978-3-030-67171-6_4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-3-030-67171-6_4</ArticleId>
            <ArticleId IdType="pubmed">33779914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009;19:43–51. doi: 10.1016/j.tcb.2008.11.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tcb.2008.11.003</ArticleId>
            <ArticleId IdType="pubmed">19144520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nederveen JP, Warnier G, Di Carlo A, Nilsson MI, Tarnopolsky MA. Extracellular vesicles and exosomes: insights from exercise science. Front Physiol. 2021;11:604–274. doi: 10.3389/fphys.2020.604274.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphys.2020.604274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paulaitis M, Agarwal K, Nana-Sinkam P. Dynamic scaling of exosome sizes. Langmuir. 2018;34:9387–9393. doi: 10.1021/acs.langmuir.7b04080.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.langmuir.7b04080</ArticleId>
            <ArticleId IdType="pmc">PMC6092198</ArticleId>
            <ArticleId IdType="pubmed">29542322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doyle L, Wang M. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019;8:727. doi: 10.3390/cells8070727.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cells8070727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simons M, Raposo G. Exosomes—vesicular carriers for intercellular communication. Curr Opin Cell Biol. 2009;21:575–581. doi: 10.1016/j.ceb.2009.03.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ceb.2009.03.007</ArticleId>
            <ArticleId IdType="pubmed">19442504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thompson AG, Gray E, Heman-Ackah SM, Mäger I, Talbot K, El Andaloussi S, et al.  Extracellular vesicles in neurodegenerative disease-pathogenesis to biomarkers. Nat Rev Neurol. 2016;12:346–357. doi: 10.1038/nrneurol.2016.68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneurol.2016.68</ArticleId>
            <ArticleId IdType="pubmed">27174238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes) J Biol Chem. 1987;262:9412–9420. doi: 10.1016/S0021-9258(18)48095-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0021-9258(18)48095-7</ArticleId>
            <ArticleId IdType="pubmed">3597417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977. doi: 10.1126/science.aau6977.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.aau6977</ArticleId>
            <ArticleId IdType="pmc">PMC7717626</ArticleId>
            <ArticleId IdType="pubmed">32029601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watson LS, Hamlett ED, Stone TD, Sims-Robinson C. Neuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer’s disease. Mol Neurodegeneration. 2019;14:22. doi: 10.1186/s13024-019-0317-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13024-019-0317-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krämer-Albers EM, Bretz N, Tenzer S, Winterstein C, Möbius W, Berger H, et al.  Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: trophic support for axons? Proteomics Clin Appl. 2007;1:1446–1461. doi: 10.1002/prca.200700522.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/prca.200700522</ArticleId>
            <ArticleId IdType="pubmed">21136642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Potolicchio I, Carven GJ, Xu X, Stipp C, Riese RJ, Stern LJ, et al.  Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J Immunol. 2005;175:2237–2243. doi: 10.4049/jimmunol.175.4.2237.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.175.4.2237</ArticleId>
            <ArticleId IdType="pubmed">16081791</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venturini A, Passalacqua M, Pelassa S, Pastorino F, Tedesco M, Cortese K, et al.  Exosomes from astrocyte processes: signaling to neurons. Front Pharmacol. 2019;10:1452. doi: 10.3389/fphar.2019.01452.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2019.01452</ArticleId>
            <ArticleId IdType="pmc">PMC6901013</ArticleId>
            <ArticleId IdType="pubmed">31849688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McAndrews KM, Kalluri R. Mechanisms associated with biogenesis of exosomes in cancer. Mol Cancer. 2019;18:52. doi: 10.1186/s12943-019-0963-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12943-019-0963-9</ArticleId>
            <ArticleId IdType="pmc">PMC6441149</ArticleId>
            <ArticleId IdType="pubmed">30925917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuan Q, Li X, Zhang S, Wang H, Wang Y. Extracellular vesicles in neurodegenerative diseases: insights and new perspectives. Genes Dis. 2020;8:124–132. doi: 10.1016/j.gendis.2019.12.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gendis.2019.12.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muraoka S, Jedrychowski MP, Tatebe H, DeLeo AM, Ikezu S, Tokuda T, et al.  Proteomic profiling of extracellular vesicles isolated from cerebrospinal fluid of former national football league players at risk for chronic traumatic encephalopathy. Front Neurosci. 2019;13:1059. doi: 10.3389/fnins.2019.01059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2019.01059</ArticleId>
            <ArticleId IdType="pmc">PMC6794346</ArticleId>
            <ArticleId IdType="pubmed">31649498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu M, Ouyang Y, Wang Z, Zhang R, Huang PH, Chen C, et al.  Isolation of exosomes from whole blood by integrating acoustics and microfluidics. Proc Natl Acad Sci USA. 2017;114:10584–10589. doi: 10.1073/pnas.1709210114.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1709210114</ArticleId>
            <ArticleId IdType="pmc">PMC5635903</ArticleId>
            <ArticleId IdType="pubmed">28923936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Street JM, Koritzinsky EH, Glispie DM, Star RA, Yuen PST. Urine exosomes: an emerging trove of biomarkers. Adv Clin Chem. 2017;78:103–122. doi: 10.1016/bs.acc.2016.07.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/bs.acc.2016.07.003</ArticleId>
            <ArticleId IdType="pubmed">28057185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han Y, Jia L, Zheng Y, Li W. Salivary exosomes: emerging roles in systemic disease. Int J Biol Sci. 2018;14:633–643. doi: 10.7150/ijbs.25018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/ijbs.25018</ArticleId>
            <ArticleId IdType="pmc">PMC6001649</ArticleId>
            <ArticleId IdType="pubmed">29904278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iranifar E, Seresht BM, Momeni F, Fadaei E, Mehr MH, Ebrahimi Z, et al.  Exosomes and microRNAs: new potential therapeutic candidates in Alzheimer disease therapy. J Cell Physiol. 2019;234:2296–2305. doi: 10.1002/jcp.27214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.27214</ArticleId>
            <ArticleId IdType="pubmed">30191975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Witwer KW, Théry C. Extracellular vesicles or exosomes? On primacy, precision, and popularity influencing a choice of nomenclature. J Extracell Vesicles. 2019;8:1648167J. doi: 10.1080/20013078.2019.1648167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/20013078.2019.1648167</ArticleId>
            <ArticleId IdType="pmc">PMC6711079</ArticleId>
            <ArticleId IdType="pubmed">31489144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750. doi: 10.1080/20013078.2018.1535750.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/20013078.2018.1535750</ArticleId>
            <ArticleId IdType="pmc">PMC6322352</ArticleId>
            <ArticleId IdType="pubmed">30637094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huo L, Du X, Li X, Liu S, Xu Y. The emerging role of neural cell-derived exosomes in intercellular communication in health and neurodegenerative diseases. Front Neurosci. 2021;15:738442. doi: 10.3389/fnins.2021.738442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2021.738442</ArticleId>
            <ArticleId IdType="pmc">PMC8438217</ArticleId>
            <ArticleId IdType="pubmed">34531720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rastogi S, Sharma V, Bharti PS, Rani K, Modi GP, Nikolajeff F, et al.  The evolving landscape of exosomes in neurodegenerative diseases: exosomes characteristics and a promising role in early diagnosis. Int J Mol Sci. 2021;22:440. doi: 10.3390/ijms22010440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms22010440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winston CN, Romero HK, Ellisman M, Nauss S, Julovich DA, Conger T, et al.  Assessing neuronal and astrocyte derived exosomes from individuals with mild traumatic brain injury for markers of neurodegeneration and cytotoxic activity. Front Neurosci. 2019;13:1005. doi: 10.3389/fnins.2019.01005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2019.01005</ArticleId>
            <ArticleId IdType="pmc">PMC6797846</ArticleId>
            <ArticleId IdType="pubmed">31680797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian Y, Fu C, Wu Y, Lu Y, Liu X, Zhang Y. Central nervous system cell-derived exosomes in neurodegenerative diseases. Oxid Med Cell Longev. 2021;2021:9965564.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8294976</ArticleId>
            <ArticleId IdType="pubmed">34336127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colombo E, Borgiani B, Verderio C, Furlan R. Microvesicles: novel biomarkers for neurological disorders. Front Physiol. 2012;3:63. doi: 10.3389/fphys.2012.00063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphys.2012.00063</ArticleId>
            <ArticleId IdType="pmc">PMC3315111</ArticleId>
            <ArticleId IdType="pubmed">22479250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spitzer P, Mulzer LM, Oberstein TJ, Munoz LE, Lewczuk P, Kornhuber J, et al.  Microvesicles from cerebrospinal fluid of patients with Alzheimer’s disease display reduced concentrations of tau and APP protein. Sci Rep. 2019;9:7089. doi: 10.1038/s41598-019-43607-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-019-43607-7</ArticleId>
            <ArticleId IdType="pmc">PMC6506501</ArticleId>
            <ArticleId IdType="pubmed">31068645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mustapic M, Eitan E, Werner JK, Berkowitz ST, Lazaropoulos MP, Tran J, et al.  Plasma extracellular vesicles enriched for neuronal origin: a potential window into brain pathologic processes. Front Neurosci. 2017;11:278. doi: 10.3389/fnins.2017.00278.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2017.00278</ArticleId>
            <ArticleId IdType="pmc">PMC5439289</ArticleId>
            <ArticleId IdType="pubmed">28588440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373–383. doi: 10.1083/jcb.201211138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.201211138</ArticleId>
            <ArticleId IdType="pmc">PMC3575529</ArticleId>
            <ArticleId IdType="pubmed">23420871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanninen KM, Bister N, Koistinaho J, Malm T. Exosomes as new diagnostic tools in CNS diseases. Biochim Biophys Acta. 2016;1862:403–410. doi: 10.1016/j.bbadis.2015.09.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbadis.2015.09.020</ArticleId>
            <ArticleId IdType="pubmed">26432482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJA. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29:341–345. doi: 10.1038/nbt.1807.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nbt.1807</ArticleId>
            <ArticleId IdType="pubmed">21423189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng T, Pu J, Chen Y, Mao Y, Guo Z, Pan H, et al.  Plasma exosomes spread and cluster around β-amyloid plaques in an animal model of Alzheimer’s disease. Front Aging Neurosci. 2017;9:12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5285341</ArticleId>
            <ArticleId IdType="pubmed">28203202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gómez-Molina C, Sandoval M, Henzi R, Ramírez JP, Varas-Godoy M, Luarte A, et al.  Small extracellular vesicles in rat serum contain astrocyte-derived protein biomarkers of repetitive stress. Int J Neuropsychopharmacol. 2018;22:232–246. doi: 10.1093/ijnp/pyy098.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ijnp/pyy098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar A, Kim S, Su Y, Sharma M, Kumar P, Singh S, et al.  Brain cell-derived exosomes in plasma serve as neurodegeneration biomarkers in male cynomolgus monkeys self-administrating oxycodone. EBioMedicine. 2021;63:103192. doi: 10.1016/j.ebiom.2020.103192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ebiom.2020.103192</ArticleId>
            <ArticleId IdType="pmc">PMC7804975</ArticleId>
            <ArticleId IdType="pubmed">33418508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu H, Sun T, An J, Wen L, Liu F, Bu Z, et al.  Potential roles of exosomes in parkinson’s disease: from pathogenesis, diagnosis, and treatment to prognosis. Front Cell Dev Biol. 2020;8:86. doi: 10.3389/fcell.2020.00086.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcell.2020.00086</ArticleId>
            <ArticleId IdType="pmc">PMC7047039</ArticleId>
            <ArticleId IdType="pubmed">32154247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pérez M, Avila J, Hernández F. Propagation of tau via extracellular vesicles. Front Neurosci. 2019;13:698. doi: 10.3389/fnins.2019.00698.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2019.00698</ArticleId>
            <ArticleId IdType="pmc">PMC6614378</ArticleId>
            <ArticleId IdType="pubmed">31312118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun R, Wang H, Shi Y, Sun Z, Jiang H, Zhang J. Changes in the morphology, number, and pathological protein levels of plasma exosomes may help diagnose Alzheimer’s disease. J Alzheimers Dis. 2020;73:909–917. doi: 10.3233/JAD-190497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3233/JAD-190497</ArticleId>
            <ArticleId IdType="pubmed">31884461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agliardi C, Clerici M. Blood extracellular vesicles (EVs) of central nervous system origin: a window into the brain. Neural Regen Res. 2020;15:55–56. doi: 10.4103/1673-5374.264454.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/1673-5374.264454</ArticleId>
            <ArticleId IdType="pmc">PMC6862414</ArticleId>
            <ArticleId IdType="pubmed">31535644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang C, Hopfner F, Berg D, Hu MT, Pilotto A, Borroni B, et al.  Validation of α-synuclein in L1CAM-immunocaptured exosomes as a biomarker for the stratification of Parkinsonian syndromes. Mov Disord. 2021;36:2663–2669. doi: 10.1002/mds.28591.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mds.28591</ArticleId>
            <ArticleId IdType="pmc">PMC8663480</ArticleId>
            <ArticleId IdType="pubmed">33826157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yousif G, Qadri S, Parray A, Akhthar N, Shuaib A, Haik Y. Exosomes derived neuronal markers: immunoaffinity isolation and characterization. Neuromolecular Med. 2021 doi: 10.1007/s12017-021-08696-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12017-021-08696-6</ArticleId>
            <ArticleId IdType="pubmed">34811658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goetzl EJ, Mustapic M, Kapogiannis D, Eitan E, Lobach IV, Goetzl L, et al.  Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer’s disease. FASEB J. 2016;30:3853–3859. doi: 10.1096/fj.201600756R.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.201600756R</ArticleId>
            <ArticleId IdType="pmc">PMC5067254</ArticleId>
            <ArticleId IdType="pubmed">27511944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dutta S, Hornung S, Kruayatidee A, Maina KN, del Rosario I, Paul KC, et al.  α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy. Acta Neuropathol. 2021;142:513. doi: 10.1007/s00401-021-02332-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-021-02332-0</ArticleId>
            <ArticleId IdType="pmc">PMC8587231</ArticleId>
            <ArticleId IdType="pubmed">34028589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saman S, Kim WH, Raya M, Visnick Y, Miro S, Saman S, et al.  Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. Biol Chem. 2012;287:3842–3849. doi: 10.1074/jbc.M111.277061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M111.277061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiasserini D, Van Weering JRT, Piersma SR, Pham TV, Malekzadeh A, Teunissen CE, et al.  Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. J Proteomics. 2014;106:191–204. doi: 10.1016/j.jprot.2014.04.028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jprot.2014.04.028</ArticleId>
            <ArticleId IdType="pubmed">24769233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guix FX, Corbett GT, Cha DJ, Mustapic M, Liu W, Mengel D, et al.  Detection of aggregation-competent tau in neuron-derived extracellular vesicles. Int J Mol Sci. 2018;19:663. doi: 10.3390/ijms19030663.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms19030663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stuendl A, Kunadt M, Kruse N, Bartels C, Moebius W, Danzer KM, et al.  Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies. Brain. 2016;139:481–494. doi: 10.1093/brain/awv346.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awv346</ArticleId>
            <ArticleId IdType="pmc">PMC4805087</ArticleId>
            <ArticleId IdType="pubmed">26647156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eusebi P, Giannandrea D, Biscetti L, Abraha I, Chiasserini D, Orso M, et al.  Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2017;32:1389–1400. doi: 10.1002/mds.27110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mds.27110</ArticleId>
            <ArticleId IdType="pubmed">28880418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kunadt M, Eckermann K, Stuendl A, Gong J, Russo B, Strauss K, et al.  Extracellular vesicle sorting of α-synuclein is regulated by sumoylation. Acta Neuropathol. 2015;129:695–713. doi: 10.1007/s00401-015-1408-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-015-1408-1</ArticleId>
            <ArticleId IdType="pmc">PMC4405286</ArticleId>
            <ArticleId IdType="pubmed">25778619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong Z, Tian C, Stewart T, Aro P, Soltys D, Bercow M, et al.  Development of a sensitive diagnostic assay for Parkinson disease quantifying α-synuclein-containing extracellular vesicles. Neurology. 2021;96:e2332–e2345. doi: 10.1212/WNL.0000000000011853.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000011853</ArticleId>
            <ArticleId IdType="pmc">PMC8166433</ArticleId>
            <ArticleId IdType="pubmed">34032594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang L, Zhang L. Circulating exosomal miRNA as diagnostic biomarkers of neurodegenerative diseases. Eur Rev Med Pharmacol Sci. 2020;22:5278–5283.</Citation>
        </Reference>
        <Reference>
          <Citation>Manna I, de Benedittis S, Quattrone A, Maisano D, Iaccino E, Quattrone A. Exosomal miRNAs as potential diagnostic biomarkers in Alzheimer’s disease. Pharmaceuticals. 2020;13:243. doi: 10.3390/ph13090243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ph13090243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, et al.  Identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case–control study. Alzheimers Dement. 2015;11:600–7.e1. doi: 10.1016/j.jalz.2014.06.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jalz.2014.06.008</ArticleId>
            <ArticleId IdType="pmc">PMC4329112</ArticleId>
            <ArticleId IdType="pubmed">25130657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, et al.  Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology. 2015;85:40–47. doi: 10.1212/WNL.0000000000001702.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000001702</ArticleId>
            <ArticleId IdType="pmc">PMC4501943</ArticleId>
            <ArticleId IdType="pubmed">26062630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jia L, Qiu Q, Zhang H, Chu L, Du Y, Zhang J, et al.  Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid. Alzheimers Dement. 2019;15:1071–1080. doi: 10.1016/j.jalz.2019.05.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jalz.2019.05.002</ArticleId>
            <ArticleId IdType="pubmed">31422798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Norman M, Ter-Ovanesyan D, Trieu W, Lazarovits R, Kowal EJK, Lee JH, et al.  L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma. Nat Methods. 2021;18:631–634. doi: 10.1038/s41592-021-01174-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41592-021-01174-8</ArticleId>
            <ArticleId IdType="pmc">PMC9075416</ArticleId>
            <ArticleId IdType="pubmed">34092791</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arioz BI, Tufekci KU, Olcum M, Durur DY, Akarlar BA, Ozlu N, et al.  Proteome profiling of neuron-derived exosomes in Alzheimer’s disease reveals hemoglobin as a potential biomarker. Neurosci Lett. 2021;755:135–914. doi: 10.1016/j.neulet.2021.135914.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neulet.2021.135914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winston CN, Goetzl EJ, Akers JC, Carter BS, Rockenstein EM, Galasko D, et al.  Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile. Alzheimers Dement. 2016;3:63–72.</Citation>
        </Reference>
        <Reference>
          <Citation>Goetzl EJ, Kapogiannis D, Schwartz JB, Lobach IV, Goetzl L, Abner EL, et al.  Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s disease. FASEB J. 2016;30:4141–4148. doi: 10.1096/fj.201600816R.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.201600816R</ArticleId>
            <ArticleId IdType="pmc">PMC5102122</ArticleId>
            <ArticleId IdType="pubmed">27601437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kapogiannis D, Boxer A, Schwartz JB, Abner EL, Biragyn A, Masharani U, et al.  Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer’s disease. FASEB J. 2015;29:589–596. doi: 10.1096/fj.14-262048.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.14-262048</ArticleId>
            <ArticleId IdType="pmc">PMC4314222</ArticleId>
            <ArticleId IdType="pubmed">25342129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goetzl EJ, Abner EL, Jicha GA, Kapogiannis D, Schwartz JB. Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer’s disease. FASEB J. 2018;32:888–893. doi: 10.1096/fj.201700731R.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.201700731R</ArticleId>
            <ArticleId IdType="pmc">PMC5888398</ArticleId>
            <ArticleId IdType="pubmed">29025866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, et al.  Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease. Acta Neuropathol. 2014;128:639–650. doi: 10.1007/s00401-014-1314-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-014-1314-y</ArticleId>
            <ArticleId IdType="pmc">PMC4201967</ArticleId>
            <ArticleId IdType="pubmed">24997849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, et al.  CNS tau efflux via exosomes is likely increased in Parkinson’s disease but not in Alzheimer’s disease. Alzheimers Dement. 2016;12:1125–1131. doi: 10.1016/j.jalz.2016.04.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jalz.2016.04.003</ArticleId>
            <ArticleId IdType="pmc">PMC5107127</ArticleId>
            <ArticleId IdType="pubmed">27234211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H, Atik A, Stewart T, Ginghina C, Aro P, Kerr KF, et al.  Plasma α-synuclein and cognitive impairment in the Parkinson’s associated risk syndrome: a pilot study. Neurobiol Dis. 2019;116:53–59. doi: 10.1016/j.nbd.2018.04.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nbd.2018.04.015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang C, Hopfner F, Hopfner F, Katsikoudi A, Hein R, Catli C, et al.  Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism. J Neurol Neurosurg Psychiatry. 2020;91:720–729. doi: 10.1136/jnnp-2019-322588.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp-2019-322588</ArticleId>
            <ArticleId IdType="pmc">PMC7361010</ArticleId>
            <ArticleId IdType="pubmed">32273329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agliardi C, Meloni M, Guerini FR, Zanzottera M, Bolognesi E, Baglio F, et al.  Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson’s disease. Neurobiol Dis. 2021;148:105185. doi: 10.1016/j.nbd.2020.105185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nbd.2020.105185</ArticleId>
            <ArticleId IdType="pubmed">33217562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chung CC, Chan L, Chen JH, Bamodu OA, Chiu HW, Hong CT. Plasma extracellular vesicles tau and β-amyloid as biomarkers of cognitive dysfunction of Parkinson’s disease. FASEB J. 2021;35:e21895.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34478572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, et al.  Cells release prions in association with exosomes. Proc Natl Acad Sci USA. 2004;101:9683–9688. doi: 10.1073/pnas.0308413101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0308413101</ArticleId>
            <ArticleId IdType="pmc">PMC470735</ArticleId>
            <ArticleId IdType="pubmed">15210972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saá P, Yakovleva O, de Castro J, Vasilyeva I, De Paoli S, Simak J, et al.  First demonstration of PrPTSE in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification of misfolded prion protein. J Biol Chem. 2014;289:29247–29260. doi: 10.1074/jbc.M114.589564.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M114.589564</ArticleId>
            <ArticleId IdType="pmc">PMC4200276</ArticleId>
            <ArticleId IdType="pubmed">25157106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Properzi F, Logozzi M, Abdel-Haq H, Federici C, Lugini L, Azzarito T, et al.  Detection of exosomal prions in blood by immunochemistry techniques. J Gen Virol. 2015;96:1969–1974. doi: 10.1099/vir.0.000117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/vir.0.000117</ArticleId>
            <ArticleId IdType="pubmed">25805411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng L, Zhao W, Hill AF. Exosomes and their role in the intercellular trafficking of normal and disease associated prion proteins. Mol Aspects Med. 2018;60:62–68. doi: 10.1016/j.mam.2017.11.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mam.2017.11.011</ArticleId>
            <ArticleId IdType="pubmed">29196098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Février B, Vilette D, Laude H, Raposo G. Exosomes: a bubble ride for prions? Traffic. 2005;6:10–17. doi: 10.1111/j.1600-0854.2004.00247.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1600-0854.2004.00247.x</ArticleId>
            <ArticleId IdType="pubmed">15569241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hartmann A, Muth C, Dabrowski O, Krasemann S, Glatzel M. Exosomes and the prion protein: more than one truth. Front Neurosci. 2017;11:194. doi: 10.3389/fnins.2017.00194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2017.00194</ArticleId>
            <ArticleId IdType="pmc">PMC5395619</ArticleId>
            <ArticleId IdType="pubmed">28469550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schenkels LCPM, Veerman ECI, Amerongen AVN. Biochemical composition of human saliva in relation to other mucosal fluids. Crit Rev Oral Biol Med. 1995;6:161–175. doi: 10.1177/10454411950060020501.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/10454411950060020501</ArticleId>
            <ArticleId IdType="pubmed">7548622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zlotogorski-Hurvitz A, Dayan D, Chaushu G, Korvala J, Salo T, Sormunen R, et al.  Human saliva-derived exosomes: comparing methods of isolation. J Histochem Cytochem. 2015;63:181–189. doi: 10.1369/0022155414564219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1369/0022155414564219</ArticleId>
            <ArticleId IdType="pmc">PMC4340734</ArticleId>
            <ArticleId IdType="pubmed">25473095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao Z, Wu Y, Liu G, Jiang Y, Wang X, Wang Z, et al.  α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson’s disease. Neurosci Lett. 2019;696:114–120. doi: 10.1016/j.neulet.2018.12.030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neulet.2018.12.030</ArticleId>
            <ArticleId IdType="pubmed">30579996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rani K, Mukherjee R, Singh E, Kumar S, Sharma V, Vishwakarma P, et al.  Neuronal exosomes in saliva of Parkinson’s disease patients: a pilot study. Parkinsonism Relat Disord. 2019;67:21–23. doi: 10.1016/j.parkreldis.2019.09.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.parkreldis.2019.09.008</ArticleId>
            <ArticleId IdType="pubmed">31621600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang S, Kojima K, Mobley JA, West AB. Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease. EBioMedicine. 2019;45:351–361. doi: 10.1016/j.ebiom.2019.06.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ebiom.2019.06.021</ArticleId>
            <ArticleId IdType="pmc">PMC6642358</ArticleId>
            <ArticleId IdType="pubmed">31229437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ho DH, Yi S, Seo H, Son I, Seol W. Increased DJ-1 in urine exosome of Korean males with Parkinson’s disease. Biomed Res Int. 2014;2014:704678.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4247948</ArticleId>
            <ArticleId IdType="pubmed">25478574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fraser KB, Rawlins AB, Clark RG, Alcalay RN, Standaert DG, Liu N, et al.  Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson’s disease. Mov Disord. 2016;31:1543–1550. doi: 10.1002/mds.26686.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mds.26686</ArticleId>
            <ArticleId IdType="pmc">PMC5053851</ArticleId>
            <ArticleId IdType="pubmed">27297049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang S, Liu Z, Ye T, Mabrouk OS, Maltbie T, Aasly J, et al.  Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers. Acta Neuropathol Commun. 2017;5:86. doi: 10.1186/s40478-017-0492-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40478-017-0492-y</ArticleId>
            <ArticleId IdType="pmc">PMC5700679</ArticleId>
            <ArticleId IdType="pubmed">29166931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun R, Wang H, Shi Y, Gao D, Sun Z, Chen Z, et al.  A pilot study of urinary exosomes in Alzheimer’s disease. Neurodegener Dis. 2020;19:184–191. doi: 10.1159/000505851.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000505851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Momen-Heravi F, Balaj L, Alian S, Mantel PY, Halleck AE, Trachtenberg AJ, et al.  Current methods for the isolation of extracellular vesicles. Biol Chem. 2013;394:1253–1262. doi: 10.1515/hsz-2013-0141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1515/hsz-2013-0141</ArticleId>
            <ArticleId IdType="pmc">PMC7075462</ArticleId>
            <ArticleId IdType="pubmed">23770532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. Chapter 3, 2006.</Citation>
        </Reference>
        <Reference>
          <Citation>Coughlan C, Bruce KD, Burgy O, Boyd TD, Michel CR, Garcia-Perez JE, et al.  Exosome isolation by ultracentrifugation and precipitation and techniques for downstream analyses. Curr Protoc Cell Biol. 2010;88:e110.</Citation>
        </Reference>
        <Reference>
          <Citation>Lobb RJ, Becker M, Wen SW, Wong CSF, Wiegmans AP, Leimgruber A, et al.  Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles. 2015;4:27031. doi: 10.3402/jev.v4.27031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3402/jev.v4.27031</ArticleId>
            <ArticleId IdType="pmc">PMC4507751</ArticleId>
            <ArticleId IdType="pubmed">26194179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu LL, Zhu J, Liu JX, Jiang F, Ni WK, Qu LS, et al.  A comparison of traditional and novel methods for the separation of exosomes from human samples. Biomed Res Int. 2018;2018:3634563.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6083592</ArticleId>
            <ArticleId IdType="pubmed">30148165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raposo G, Nijman HW, Stoorvogel W, Leijendekker R, Harding CV, Melief CJM, et al.  B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183:1161–1172. doi: 10.1084/jem.183.3.1161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.183.3.1161</ArticleId>
            <ArticleId IdType="pmc">PMC2192324</ArticleId>
            <ArticleId IdType="pubmed">8642258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheruvanky A, Zhou H, Pisitkun T, Kopp JB, Knepper MA, Yuen PST, et al.  Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. Am J Physiol Renal Physiol. 2007;292:F1657–F1661. doi: 10.1152/ajprenal.00434.2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00434.2006</ArticleId>
            <ArticleId IdType="pmc">PMC2271070</ArticleId>
            <ArticleId IdType="pubmed">17229675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hou R, Li Y, Sui Z, Yuan H, Yang K, Liang Z, et al.  Advances in exosome isolation methods and their applications in proteomic analysis of biological samples. Anal Bioanal Chem. 2019;411:5351–5361. doi: 10.1007/s00216-019-01982-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00216-019-01982-0</ArticleId>
            <ArticleId IdType="pubmed">31267193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang P, Zhou X, He M, Shang Y, Tetlow AL, Godwin AK, et al.  Ultrasensitive detection of circulating exosomes with a 3D-nanopatterned microfluidic chip. Nat Biomed Eng. 2019;3:438–451. doi: 10.1038/s41551-019-0356-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41551-019-0356-9</ArticleId>
            <ArticleId IdType="pmc">PMC6556143</ArticleId>
            <ArticleId IdType="pubmed">31123323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anastasi F, Masciandaro SM, Del Carratore R, Dell’anno MT, Signore G, Falleni A, , et al.  Proteomics profiling of neuron-derived small extracellular vesicles from human plasma: Enabling single-subject analysis. Int J Mol Sci. 2021;22:2951. doi: 10.3390/ijms22062951.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms22062951</ArticleId>
            <ArticleId IdType="pmc">PMC7999506</ArticleId>
            <ArticleId IdType="pubmed">33799461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joncas FH, Lucien F, Rouleau M, Morin F, Leong HS, Pouliot F, et al.  Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients. Prostate. 2019;79:1767–1776. doi: 10.1002/pros.23901.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pros.23901</ArticleId>
            <ArticleId IdType="pubmed">31475741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menon R, Debnath C, Lai A, Guanzon D, Bhatnagar S, Kshetrapal P, et al.  Protein profile changes in circulating placental extracellular vesicles in term and preterm births: a longitudinal study. Endocrinology. 2020;161:bqaa009. doi: 10.1210/endocr/bqaa009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/endocr/bqaa009</ArticleId>
            <ArticleId IdType="pmc">PMC7102872</ArticleId>
            <ArticleId IdType="pubmed">31995166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alvarez ML, Khosroheidari M, Kanchi Ravi R, Distefano JK. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 2012;82:1024–1032. doi: 10.1038/ki.2012.256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2012.256</ArticleId>
            <ArticleId IdType="pubmed">22785172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ayala-Mar S, Donoso-Quezada J, Gallo-Villanueva RC, Perez-Gonzalez VH, González-Valdez J. Recent advances and challenges in the recovery and purification of cellular exosomes. Electrophoresis. 2019;40:3036–3049. doi: 10.1002/elps.201800526.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/elps.201800526</ArticleId>
            <ArticleId IdType="pmc">PMC6972601</ArticleId>
            <ArticleId IdType="pubmed">31373715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics. 2017;7:789–804. doi: 10.7150/thno.18133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/thno.18133</ArticleId>
            <ArticleId IdType="pmc">PMC5327650</ArticleId>
            <ArticleId IdType="pubmed">28255367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davies RT, Kim J, Jang SC, Choi EJ, Gho YS, Park J. Microfluidic filtration system to isolate extracellular vesicles from blood. Lab Chip. 2012;12:5202–5210. doi: 10.1039/c2lc41006k.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/c2lc41006k</ArticleId>
            <ArticleId IdType="pubmed">23111789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee K, Shao H, Weissleder R, Lee H. Acoustic purification of extracellular microvesicles. ACS Nano. 2015;9:2321–2327. doi: 10.1021/nn506538f.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/nn506538f</ArticleId>
            <ArticleId IdType="pmc">PMC4373978</ArticleId>
            <ArticleId IdType="pubmed">25672598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Contreras-Naranjo JC, Wu HJ, Ugaz VM. Microfluidics for exosome isolation and analysis: enabling liquid biopsy for personalized medicine. Lab Chip. 2017;17:3558–3577. doi: 10.1039/C7LC00592J.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/C7LC00592J</ArticleId>
            <ArticleId IdType="pmc">PMC5656537</ArticleId>
            <ArticleId IdType="pubmed">28832692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kashefi-Kheyrabadi L, Kim J, Chakravarty S, Park S, Gwak H, Kim S, et al.  Detachable microfluidic device implemented with electrochemical aptasensor (DeMEA) for sequential analysis of cancerous exosomes. Biosens Bioelectron. 2020;169:112622. doi: 10.1016/j.bios.2020.112622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bios.2020.112622</ArticleId>
            <ArticleId IdType="pubmed">32977087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J, Lee H, Park K, Shin S. Rapid and efficient isolation of exosomes by clustering and scattering. J Clin Med. 2020;9:650. doi: 10.3390/jcm9030650.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm9030650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian X, Zhu M, Nie G. How can nanotechnology help membrane vesicle-based cancer immunotherapy development? Hum Vaccin Immunother. 2013;9:222–225. doi: 10.4161/hv.22130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/hv.22130</ArticleId>
            <ArticleId IdType="pmc">PMC3667943</ArticleId>
            <ArticleId IdType="pubmed">23108359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nemati Z, Kouhpanji MRZ, Zhou F, Das R, Makielski K, Um J, et al.  Isolation of cancer-derived exosomes using a variety of magnetic nanostructures: from fe3 o4 nanoparticles to ni nanowires. Nanomaterials. 2020;10:1662. doi: 10.3390/nano10091662.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/nano10091662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong W, Lee S, Chang HJ, Lee ES, Cho Y. Multifunctional magnetic nanowires: a novel breakthrough for ultrasensitive detection and isolation of rare cancer cells from non-metastatic early breast cancer patients using small volumes of blood. Biomaterials. 2016;106:78–86. doi: 10.1016/j.biomaterials.2016.08.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biomaterials.2016.08.020</ArticleId>
            <ArticleId IdType="pubmed">27552318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee HJ, Jeon SH, Seo JS, Goh SH, Han JY, Cho Y. A novel strategy for highly efficient isolation and analysis of circulating tumor-specific cell-free DNA from lung cancer patients using a reusable conducting polymer nanostructure. Biomaterials. 2016;101:251–257. doi: 10.1016/j.biomaterials.2016.06.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biomaterials.2016.06.003</ArticleId>
            <ArticleId IdType="pubmed">27294542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim J, Choi M, Lee H, Kim YH, Han JY, Lee ES, et al.  Direct isolation and characterization of circulating exosomes from biological samples using magnetic nanowires. J Nanobiotechnology. 2019;17:1. doi: 10.1186/s12951-018-0433-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12951-018-0433-3</ArticleId>
            <ArticleId IdType="pmc">PMC6322342</ArticleId>
            <ArticleId IdType="pubmed">30612562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang W, Yu ZL, Wu M, Ren JG, Xia HF, Sa GL, et al.  Magnetic and folate functionalization enables rapid isolation and enhanced tumor-targeting of cell-derived microvesicles. ACS Nano. 2017;11:277–290. doi: 10.1021/acsnano.6b05630.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acsnano.6b05630</ArticleId>
            <ArticleId IdType="pubmed">28005331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kabe Y, Suematsu M, Sakamoto S, Hirai M, Koike I, Hishiki T, et al.  Development of a highly sensitive device for counting the number of disease-specific exosomes in human sera. Clin Chem. 2018;64:1463–1473. doi: 10.1373/clinchem.2018.291963.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1373/clinchem.2018.291963</ArticleId>
            <ArticleId IdType="pubmed">30021922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sidhom K, Obi PO, Saleem A. A review of exosomal isolation methods: Is size exclusion chromatography the best option? Int J Mol Sci. 2020;21:6466. doi: 10.3390/ijms21186466.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21186466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Böing AN, van der Pol E, Grootemaat AE, Coumans FAW, Sturk A, Nieuwland R. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles. 2014 doi: 10.3402/jev.v3.23430.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3402/jev.v3.23430</ArticleId>
            <ArticleId IdType="pmc">PMC4263901</ArticleId>
            <ArticleId IdType="pubmed">25498889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stranska R, Gysbrechts L, Wouters J, Vermeersch P, Bloch K, Dierickx D, et al.  Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma. J Transl Med. 2018;16:1. doi: 10.1186/s12967-017-1374-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12967-017-1374-6</ArticleId>
            <ArticleId IdType="pmc">PMC5761138</ArticleId>
            <ArticleId IdType="pubmed">29316942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baranyai T, Herczeg K, Onódi Z, Voszka I, Módos K, Marton N, et al.  Isolation of exosomes from blood plasma: qualitative and quantitative comparison of ultracentrifugation and size exclusion chromatography methods. PLoS ONE. 2015;10:e0145686. doi: 10.1371/journal.pone.0145686.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0145686</ArticleId>
            <ArticleId IdType="pmc">PMC4686892</ArticleId>
            <ArticleId IdType="pubmed">26690353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol EA, Goumans MJ, Doevendans PA, Sluijter JPG, Vader P. Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugation. Nanomedicine. 2017;13:2061–2065. doi: 10.1016/j.nano.2017.03.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nano.2017.03.011</ArticleId>
            <ArticleId IdType="pubmed">28365418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guerreiro EM, Vestad B, Steffensen LA, Aass HCD, Saeed M, Øvstebø R, et al.  Efficient extracellular vesicle isolation by combining cell media modifications, ultrafiltration, and size-exclusion chromatography. PLoS ONE. 2018;13:e0204276. doi: 10.1371/journal.pone.0204276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0204276</ArticleId>
            <ArticleId IdType="pmc">PMC6160036</ArticleId>
            <ArticleId IdType="pubmed">30260987</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
